Cardiovascular disease as a late complication of end-stage renal disease in children

被引:0
|
作者
Jaap W. Groothoff
Marc R. Lilien
Nicole C. A. J. van de Kar
Eric D. Wolff
Jean Claude Davin
机构
[1] Emma Children’s Hospital AMC,Department of Pediatric Nephrology, Emma Children’s Hospital AMC
[2] Wilhelmina Children’s Hospital,undefined
[3] University Medical Center St. Radboud,undefined
[4] Sophia Children’s Hospital,undefined
[5] University of Amsterdam,undefined
来源
Pediatric Nephrology | 2005年 / 20卷
关键词
End-stage renal disease; Arterial stiffening; Left ventricular hypertrophy; Calcification;
D O I
暂无
中图分类号
学科分类号
摘要
As in older adults, cardiovascular disease is the most important cause of death in adolescents and young adult patients with end-stage renal disease (ESRD) since childhood. This concerns patients on dialysis as well as transplant patients, despite the fact that a long duration of dialysis during childhood is an extra mortality risk factor. Left ventricular hypertrophy (LVH), aortic valve calcification, and increased arterial stiffness, but not increased arterial intima media thickening, are the most frequently observed alterations in young adult survivors with childhood ESRD. In transplanted patients a concentric LVH as a result of chronic hypertension is mostly observed; in dialysis patients a more asymmetric septal LVH is found as a result of chronic volume overload. These results suggest that in children and young adults with ESRD chronic pressure and volume overload, a high calcium-phosphate product, and chronic inflammation, but not dyslipidemia, play a role in the development of cardiovascular disease.
引用
收藏
页码:374 / 379
页数:5
相关论文
共 50 条
  • [1] Cardiovascular disease as a late complication of end-stage renal disease in children
    Groothoff, JW
    Lilien, MR
    van de Kar, NCAJ
    Wolff, ED
    Davin, JC
    [J]. PEDIATRIC NEPHROLOGY, 2005, 20 (03) : 374 - 379
  • [2] Cardiovascular disease as a late complication of end-stage renal disease in children
    Groothoff, J
    Gruppen, M
    de Groot, E
    Offringa, M
    [J]. PERITONEAL DIALYSIS INTERNATIONAL, 2005, 25 : S123 - S126
  • [3] Cardiovascular disease in end-stage renal disease
    Park, Jung Tak
    Oh, Hyung Jung
    Kang, Shin-Wook
    [J]. JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2013, 56 (07): : 576 - 582
  • [4] Prevalence and predictors of aortic dilation as a novel cardiovascular complication in children with end-stage renal disease
    Kaddourah, Ahmad
    Uthup, Susan
    Madueme, Peace
    O'Rourke, Matthew
    Hooper, David K.
    Taylor, Michael D.
    Colan, Steven D.
    Jefferies, John L.
    Rao, Marepalli B.
    Goebel, Jens
    [J]. CLINICAL NEPHROLOGY, 2015, 83 (05) : 262 - 271
  • [5] The epidemic of cardiovascular disease in end-stage renal disease
    Brenner, RM
    Wrone, EM
    [J]. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 1999, 8 (03): : 365 - 369
  • [6] Cardiovascular disease in end-stage renal disease patients
    Collins, AJ
    Li, SL
    Ma, JZ
    Herzog, C
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (04) : S26 - S29
  • [7] The Cardiovascular Burden in End-Stage Renal Disease
    Cozzolino, Mario
    Galassi, Andrea
    Pivari, Francesca
    Ciceri, Paola
    Conte, Ferruccio
    [J]. EXPANDED HEMODIALYSIS: INNOVATIVE CLINICAL APPROACH IN DIALYSIS, 2017, 191 : 44 - 57
  • [8] Cardiovascular calcification in end-stage renal disease
    Salusky, IB
    Goodman, WG
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 (02) : 336 - 339
  • [9] Cardiovascular mortality in end-stage renal disease
    Collins, AJ
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2003, 325 (04): : 163 - 167
  • [10] Hemodialysis in children with end-stage renal disease
    Dominik Müller
    Stuart L. Goldstein
    [J]. Nature Reviews Nephrology, 2011, 7 : 650 - 658